ベインのウェブサイトは、ユーザーの、利便性の向上、と機能改善のために、クッキーを使用しています。詳細は、弊社のプライバシーポリシーをご参照ください。このサイト閲覧を継続されることで、クッキーの使用についてご了承いただいたことになります。

スナップチャート

Doctors in India See a Rise in Digital Interactions with Pharma and Medtech Companies

Covid-19 has accelerated physicians’ use of digital channels to consume scientific content.

スナップチャート

Doctors in India See a Rise in Digital Interactions with Pharma and Medtech Companies
en

During Covid-19, the percentage of physicians in India accessing scientific content published by pharma and medtech companies has grown by more than 40%, according to research by India-based data foundation THB. Looking forward, about 85% of doctors in India believe that digital exchanges with pharma and medtech firms will be as important as (if not more important than) face-to-face interactions with sales reps, medical liaisons and marketing staff. Nearly 50% say that, in the future, they will engage with healthcare companies more via digital channels than face-to-face. As marketing to doctors in India takes a digital leap forward, successful pharma and medtech companies are starting to differentiate themselves by incorporating digital options into their commercial operating models and ensuring that they have the appropriate channels, content and formats.

This research was conducted by THB, a technology, healthcare and big data analytics company based in India.  THB's platform provides digital scientific education and helps patients connect digitally with clinicians. During the last 12 months, the platform has enabled more than 4 million patient consultations with more than 250,000 doctors. THB's platform offers physicians proprietary clinical insights, evidence and research from real-world data across more than 25 therapy areas.

Tags

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。